ChemAbout

ChemAbout is a B2B platform where chemical buyers and suppliers discover each other.

Post a purchase requestList your products (for suppliers)
© 2026 ChemAbout
Compound Index|Demand Board|Insights|Exhibitions|Compliance|Help Center|Privacy Policy|Terms of Service|[email protected]
Home/Compounds/API/Octreotide Impurity 13
C51H68N10O11S2
1061.3 g/mol
API

Octreotide Impurity 13

CAS1546983-33-8
Category
API
Compound Class
Peptide
Primary Use
Pharmaceutical Raw Material

Octreotide Impurity 13 is a chemical compound used as a pharmaceutical reference standard. It is structurally related to octreotide, a synthetic analog of the natural hormone somatostatin.

pharmaceutical reference standardanalytical research

Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.

Sourcing Octreotide Impurity 13?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→

Related Compounds

SimilarStructure SimilarSimilarity 0.81

San 201-456

CAS79486-60-5

pharmaceutical raw material

SimilarStructure SimilarSimilarity 0.79

(Cysteinol7,des-L-threoninol8)-Octreotide acetate salt

CAS1546983-18-9

pharmaceutical raw material

ApplicationSame Use

Alogliptin Impurity 14

CAS1820685-30-0

pharmaceutical raw material

ApplicationSame Use

(S)-N-((3-(3-Fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)ethanethioamide

CAS216868-57-4

pharmaceutical raw material

ApplicationSame Use

3-[4-(4-Chlorobenzoyl)phenoxy]butan-2-one

CAS217636-47-0

pharmaceutical raw material

ApplicationSame Use

1,3-Propanediol, 2-allyl-2-methyl-, dicarbamate

CAS25462-39-9

pharmaceutical raw material

ReferenceSame Category

1,1'-((1-methylethyl)imino)bis(3-(4-(2-methoxyethyl)phenoxy)propan-2-ol)

CAS154784-36-8

pharmaceutical raw material

ReferenceSame Category

CAP18

CAS154947-66-7

pharmaceutical raw material

Related Reading

Therapeutic Peptides in 2026: This Year's Breakthroughs

2026 has been a concentrated year for peptide therapeutics. Efficacy reached a new high in late-stage trials, the obesity field moved beyond the incretins to amylin, the oral route reached weight management, and peptide-guided radioligand therapy kept advancing — each point tied to a specific 2025–2026 result.

Read more
Identifiers
IUPAC Name

(4R,7S,10S,13R,16S,19R)-N-acetyl-10-(4-aminobutyl)-19-[[(2R)-2-amino-3-phenylpropanoyl]amino]-16-benzyl-N-[(2R,3R)-1,3-dihydroxybutan-2-yl]-7-[(1R)-1-hydroxyethyl]-13-(1H-indol-3-ylmethyl)-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosane-4-carboxamide

InChIKey

ARRHMGVAVQZELR-SPNVPKOWSA-N

SMILES

C[C@H]([C@H]1C(=O)N[C@@H](CSSC[C@@H](C(=O)N[C@H](C(=O)N[C@@H](C(=O)N[C@H](C(=O)N1)CCCCN)CC2=CNC3=CC=CC=C32)CC4=CC=CC=C4)NC(=O)[C@@H](CC5=CC=CC=C5)N)C(=O)N([C@H](CO)[C@@H](C)O)C(=O)C)O

Synonyms (2)
  • Octreotide Impurity 13

Sourcing Octreotide Impurity 13?

Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.

Post a Purchase Request→Supplier? List your product for this CAS→